{"schema_version":"secwatch.filing_event.v1","accession":"0001625297-25-000035","form_type":"8-K","ticker":"INDV","cik":"0001625297","company_name":"Indivior Pharmaceuticals, Inc.","filed_at":"2025-06-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.105476+00:00","generated_at":"2026-05-20T02:57:03.047898+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Indivior to cancel London Stock Exchange secondary listing, maintain Nasdaq primary listing","bullets":["London delisting effective July 25, 2025; last trading on LSE July 24, 2025.","Over 80% of net revenue from US; 75% of trading volume on Nasdaq; over 70% of shareholders by value US-based.","Nasdaq listing under INDV unaffected; direct holders and DTC broker/custodian holders unaffected.","Holders of UK Depositary Interests and Corporate Sponsored Nominee facility advised to convert holdings for Nasdaq trading.","UK Takeover Code remains applicable for 2 years after delisting; mandatory offer rules unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001625297-25-000035","json":"https://secwatch.observer/filing/0001625297-25-000035.json","markdown":"https://secwatch.observer/filing/0001625297-25-000035.md","text":"https://secwatch.observer/filing/0001625297-25-000035.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1625297/000162529725000035/0001625297-25-000035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1625297/000162529725000035/a8-k05302025.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T02:57:03.047898+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}